One-pot rapid synthesis of pyrazolyl-4-thiazolidinones
2-(3-(4-Methyl-2-phenylthiazol-5-yl)-2-phenyl-1H-pyrazol-4-yl)-3-phenylthiazoli-
1
din-4-one (6n) IR (KBr) Vmax: 3,045, 2,910, 1,680, 1,585, 765 cm-1. H NMR
(DMSO-d6, 400 MHz) d = 2.48 (3H, s, CH3), 3.85–3.89 (1H, d, J = 16 Hz),
3.97–4.01 (1H, d, J = 16 Hz), 6.41 (1H, s), 7.08–7.91 (14H, m, Ar–H), 8.85 (1H, s,
pyrazolyl). 13C NMR (DMSO-d6, 100 MHz) d = 16.2, 32.8, 55.7, 115.4, 115.8,
118.2, 121.1, 122.0, 126.1, 127.0, 128.2, 128.3, 129.2, 129.8, 130.7, 132.8, 133.6,
138.5, 141.9, 152.2, 165.8, 170.1. HRESIMS m/z (pos): 529.0923 [M ? H]? for
C28H21ClN4OS2.
Conclusions
We have developed an exceedingly simple, scalable and novel synthetic protocol for
synthesis of 4-thiazolidinone derivatives. To the best our knowledge, this is the first
report of application of diisopropylethylammonium acetate (DIPEAc) for synthesis
of 4-thiazolidinones at room temperature. The new catalytic and green medium
procedure offers the following distinct advantages: (1) one-pot multicomponent
synthesis of thiazolidinones with broad substrate scope, (2) no requirement for
additional reagents, (3) high yields, (4) ease of product isolation/purification, (5)
ease of preparation/handling of RTIL and (6) catalyst reuse that fulfils the triple
bottom-line philosophy of green chemistry. Therefore, this one-pot multicomponent
procedure clearly represents an appealing methodology for synthesis of 4-thiazo-
lidinones in both academia and pharmaceutical industry, and is even better than our
earlier efforts towards synthesis of 2-(3-(4-methyl-2-substituted thiazol-5-yl)-2-
phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-ones [3].
Acknowledgments Authors are grateful to Professor D. B. Ingle for invaluable discussion and
guidance. The authors are very grateful to CDRI, Lucknow for providing spectral facilities. Authors are
also grateful to the National Toxicology Centre (NTC), Pune for screening anti-inflammatory activity.
L.D.K. is also grateful to U.G.C., New Delhi, India for financial assistance in the form of a UGC-NET
Senior Research Fellowship.
References
1. A.K. Jain, A. Vaidya, V. Ravichandran, S.K. Kashaw, R.K. Agrawal, Bioorg. Med. Chem. 20, 3378
(2012)
2. A.C. Tripathi, S.J. Gupta, G.N. Fatima, P.K. Sonar, A. Verma, S.K. Saraf, Eur. J. Med. Chem. 72, 52
(2014)
3. L.D. Khillare, M.R. Bhosle, A.R. Deshmukh, R.A. Mane, Med. Chem. Res. (2014). doi:10.1007/
4. D. Prasad, A. Preetam, M. Nath, RSC Adv. 2, 3133 (2012)
5. T. Srivastava, W. Haq, S.B. Katti, Tetrahedron 58, 7619 (2002)
6. R.K. Rawal, T. Srivastava, W. Haq, S.B. Katti, J. Chem. Res. 5, 368 (2004)
7. C.T. Sadashivaa, J.N. Narendra, S. Chandraa, C.V. Kavithaa, A. Thimmegowdab, M.N. Subhashc,
K.S. Rangappaa, Eur. J. Med. Chem. 44, 4848 (2009)
8. S.K. Srivastava, S.L. Srivastava, J. Indian Chem. Soc. 77, 104 (2002)
9. R.C. Kumar, D. Kumar, J. Indian Chem. Soc. 77, 492 (2002)
10. A.K. Yadav, M. Kumar, T. Yadav, R. Jain, Tetrahedron Lett. 50, 5031 (2009)
11. X. Zhang, X. Li, D. Li, G. Qu, J. Wang, P.M. Loiseau, X. Fan, Bioorg. Med. Chem. Lett. 19, 6280
(2009)
123